drugset / Trial / NCT05014711

Compare the Effects of Remifentanil and Fentanyl on the Duration of Mechanical Ventilation of ICU Patients

NCT05014711

Phase 4 Unknown 254 enrolled Capital Medical University
RandomizedParallel-groupSingle-blindTreatment

Summary

To verify whether remifentanil is more beneficial to reduce the duration of mechanical ventilation, shorten the interval from SBT to extubation, reduce the incidence of adverse events, reduce the workload of nursing staff, reduce the dosage of sedatives and ICU hospitalization costs, shorten the length of ICU hospitalization, and reduce the short-term mortality.

Timeline

Start
2020-01-01
Primary completion
2021-12-31
Completion
2022-03-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fentanyl Other / unclassified 0.025 ug/kg Intravenous
Subject Remifentanil Small molecule 0.025 ug/kg Intravenous

Indications

No indication recorded.